Related Experiment Video

Updated: Oct 21, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

The De Vega tricuspid annuloplasty. Perioperative mortality and long term follow-up

R De Paulis1, M Bobbio, G Ottino

  • 1Cattedra di Cardiochirurgia, Università degli Studi di Torino, Turin, Italy.

The Journal of Cardiovascular Surgery
|July 1, 1990
PubMed

Insights

The De Vega tricuspid annuloplasty is effective for mild to moderate tricuspid insufficiency. For severe cases, alternative surgical methods may yield better outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Procedures
  • Valvular Heart Disease

Background:

  • Tricuspid regurgitation is a significant valvular heart disease.
  • Surgical repair options for tricuspid insufficiency are crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of the De Vega tricuspid annuloplasty.
  • To identify risk factors for perioperative mortality and reoperation after this procedure.

Main Methods:

  • Retrospective analysis of 153 patients undergoing De Vega tricuspid annuloplasty between 1979 and 1987.
  • Assessment of operative mortality, long-term survival, reoperation rates, and residual tricuspid regurgitation.

Main Results:

  • Operative mortality was 11.1%, with preoperative NYHA class and cardiopulmonary bypass time as significant risk factors.
  • Nine-year actuarial survival for operative survivors was 73.5%.
  • Reoperation was required in 11 patients, primarily for recurrent tricuspid regurgitation or mitral prosthesis issues.

Conclusions:

  • De Vega tricuspid annuloplasty is a suitable surgical option for mild and moderate tricuspid insufficiency.
  • For severe tricuspid regurgitation, alternative surgical approaches may be more beneficial.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...